MN-08

N/A

Report date: 2026/02/06 20:01:23
NME

Base Information

Drug NameMN-08
Drug Alias Name美金刚硝酸酯Memantine nitrateMN-08
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsSerotonin 3 (5-HT3) receptor antagonists
TargetsGlutamate [NMDA] receptorSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsHypertensionGlaucoma, Open-AngleGlaucoma +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Magpie Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGuangzhou Magpie Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertensionGlaucoma, Open-AngleGlaucoma +[7] 
Inactive IndicationsFamilial Primary Pulmonary Hypertension

Other Information

ATC CodeN/A
Related LinksN/A